|
MAK16 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.13270000000354E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.007000E-04 |
| Normal-vs-Stage2 |
4.206600E-04 |
| Normal-vs-Stage3 |
1.77277999999781E-05 |
| Normal-vs-Stage4 |
4.97600000004539E-06 |
| Stage1-vs-Stage2 |
3.049400E-01 |
| Stage1-vs-Stage3 |
8.066000E-02 |
| Stage1-vs-Stage4 |
7.006100E-02 |
| Stage2-vs-Stage3 |
8.098600E-01 |
| Stage2-vs-Stage4 |
7.324400E-01 |
| Stage3-vs-Stage4 |
8.933800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34090000000143E-05 |
| Normal-vs-AfricanAmerican |
3.120000E-02 |
| Normal-vs-Asian |
4.194100E-02 |
| Caucasian-vs-AfricanAmerican |
6.098200E-01 |
| Caucasian-vs-Asian |
1.458230E-01 |
| AfricanAmerican-vs-Asian |
6.082200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.1806000002137E-07 |
| Normal-vs-Female |
3.212000E-04 |
| Male-vs-Female |
4.140300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.616500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.54069999999973E-06 |
| Normal-vs-Age(61-80Yrs) |
1.52273999999286E-05 |
| Normal-vs-Age(81-100Yrs) |
6.220500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.628200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.753700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.210000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.058400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.765400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.742000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.447150E-01 |
| Classical-VS-Follicular |
2.26089999999513E-06 |
| Classical-VS-Other |
1.239360E-01 |
| Classical-VS-Normal |
4.897400E-03 |
| Tall-VS-Follicular |
1.601580E-01 |
| Tall-VS-Other |
4.197600E-01 |
| Tall-VS-Normal |
1.141620E-03 |
| Follicular-VS-Other |
9.859800E-01 |
| Follicular-VS-Normal |
6.10229999864487E-08 |
| Other-VS-Normal |
9.702200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.70310000000307E-06 |
| Normal-vs-N1 |
1.256630E-03 |
| N0-vs-N1 |
5.113600E-01 |
|
|
